Brady Martz Wealth Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Sell
17,701
-961
-5% -$25.1K 0.06% 157
2026
Q1
$524K Sell
18,662
-33,542
-64% -$893K 0.09% 129
2025
Q4
$1.3M Sell
52,204
-1,894
-4% -$47.8K 0.23% 78
2025
Q3
$1.38M Sell
54,098
-165
-0.3% -$4.07K 0.25% 74
2025
Q2
$1.32M Sell
54,263
-2,185
-4% -$51K 0.25% 75
2025
Q1
$1.43M Sell
56,448
-1,266
-2% -$33.1K 0.32% 67
2024
Q4
$1.52M Buy
+57,714
New +$1.57M 0.37% 63

Other funds holding PFE

Brady Martz Wealth Solutions's PFE Position: Q2 2026 in Review

Brady Martz Wealth Solutions reduced its Pfizer (PFE) stake by 5.1% in Q2 2026, selling an estimated $25.1K and leaving 17,701 shares worth $426K. The position accounts for 0.06% of the portfolio, ranked #157.

Brady Martz Wealth Solutions first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.52M in Q4 2024. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Brady Martz Wealth Solutions held 17,701 shares of Pfizer worth $426K as of Q2 2026.
  • Brady Martz Wealth Solutions sold 961 Pfizer shares in Q2 2026, an estimated $25.1K.
  • Pfizer made up 0.06% of Brady Martz Wealth Solutions's portfolio in Q2 2026, its #157 holding.
  • Brady Martz Wealth Solutions first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Brady Martz Wealth Solutions's Pfizer position peaked at $1.52M in Q4 2024.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brady Martz Wealth Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.